NCT00169130View on ClinicalTrials.gov

ACVBP Followed by ASCT in Patients With BCL-2 Positive Diffuse Large B-Cell Lymphoma

PHASE2/PHASE3CompletedINTERVENTIONAL
Enrollment

300

Participants

Timeline

Start Date

October 31, 1999

Conditions
Lymphoma, Large-Cell, Diffuse
Interventions
DRUG

doxorubicin

DRUG

cyclophosphamide

PROCEDURE

Autologous stem cell transplantation

Trial Locations (5)

75010

Hôpital Saint Louis, Paris

76000

Centre Henri Becquerel, Rouen

Unknown

Service d'Hematologie, Mont-Godinne

Hôpital Henri Mondor, Créteil

Centre Hospitalier Lyon Sud, Pierre-Bénite

All Listed Sponsors
collaborator

Fondation ARC

OTHER

lead

Lymphoma Study Association

OTHER

NCT00169130 - ACVBP Followed by ASCT in Patients With BCL-2 Positive Diffuse Large B-Cell Lymphoma | Biotech Hunter | Biotech Hunter